Psychedelics Ballot Initiatives 2020

Live Results

Update: Both Ballot Initiatives Passed

Psychedelics will be effectively decriminalised for approximately 7 million Americans. Read our review here.

DC has decriminalised psychedelics as Initiative 81 passes with significant majority. Full story here.

Many sources have Called It: Measure 109 will pass, legalizing psilocybin therapy in Oregon.

Live Results

Note: results are no longer live, as both Measure 109 and Initiative 81 have succeeded. The below data will continue to be updated periodically until final vote counts are provided.

Measure 109 (Oregon)

Psilocybin Mushroom Services Program Initiative

Yes: 1,166,798 (55.88%)
No:  921,097 (44.12%)

Initiative 81 (DC)

Entheogenic Plants and Fungus Measure

Yes: 89,714 (76.59%)
No: 27,429 (23.41%)


Oregon’s Measure 109 would mandate the creation of the Oregon Psilocybin Services Program, allowing the production, administering and sale of psilocybin mushrooms by licenced facilities.

If successful, the ballot initiative allows for a 2-year developmental period prior to the commencement of the Program.

DC’s Initiative 81 calls for the effective decriminalisation of non-commercial cultivation, distribution, possession, and use of psychedelics such as psilocybin and ibogaine by ordering police to treat them as the lowest law enforcement priorities.

Under this initiative, entheogenic plants and fungi include ibogaine, dimethyltryptamine, mescaline, psilocybin, or psilocyn.

Oregon’s approach is more structured, creating a medical psychedelics program. DC’s approach, meanwhile, is a broader decriminalisation of psychedelic plants and fungi.

If successful, Oregon and DC would join the cities of Denver, Colorado, Santa Cruz and Oakland, California, and Ann Arbor, Michigan in their efforts to begin to scale back America’s war on (psychedelic) drugs.

This potential cross-coast psychedelic decriminalisation would be a major signifier of the legitimacy afforded to these substances by the American public.

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.